4.5 Article

miR-367 promotes proliferation and stem-like traits in medulloblastoma cells

Journal

CANCER SCIENCE
Volume 106, Issue 9, Pages 1188-1195

Publisher

WILEY
DOI: 10.1111/cas.12733

Keywords

Cancer stem cell; medulloblastoma; microRNA; miR-367; pluripotency

Categories

Funding

  1. FAPESP-CEPID [2013/08028-1]
  2. FAPESP [2010/52686-5]
  3. CNPq [309206/2011-1, 444722/2014-9]
  4. INCT-CETGEN [573633/2008-8]
  5. FINEP-CTC [0108057900]
  6. FAPESP fellowship [2013/02983-1, 2011/10001-9, 2013/17566-7, 2014/10519-6]

Ask authors/readers for more resources

In medulloblastoma, abnormal expression of pluripotency factors such as LIN28 and OCT4 has been correlated with poor patient survival. The miR-302/367 cluster has also been shown to control self-renewal and pluripotency in human embryonic stem cells and induced pluripotent stem cells, but there is limited, mostly correlational, information about these pluripotency-related miRNA in cancer. We evaluated whether aberrant expression of such miRNA could affect tumor cell behavior and stem-like traits, thereby contributing to the aggressiveness of medulloblastoma cells. Basal expression of primary and mature forms of miR-367 were detected in four human medulloblastoma cell lines and expression of the latter was found to be upregulated upon enforced expression of OCT4A. Transient overexpression of miR-367 significantly enhanced tumor features typically correlated with poor prognosis; namely, cell proliferation, 3-D tumor spheroid cell invasion and the ability to generate neurosphere-like structures enriched in CD133 expressing cells. A concurrent downregulation of the miR-367 cancer-related targets RYR3, ITGAV and RAB23, was also detected in miR-367-overexpressing cells. Overall, these findings support the pro-oncogenic activity of miR-367 in medulloblastoma and reveal a possible mechanism contributing to tumor aggressiveness, which could be further explored to improve patient stratification and treatment of this important type of pediatric brain cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available